GURUFOCUS.COM » STOCK LIST » Latin America » Mexico » MEX » WuXi Biologics (Cayman) Inc (MEX:2269) » Definitions » Other Cash Receipts from Operating Activities
Switch to:

WuXi Biologics (Cayman) (MEX:2269) Other Cash Receipts from Operating Activities


View and export this data going back to 2020. Start your Free Trial

Other Cash Receipts from Operating Activities only applicable to companies reporting Cash Flow from Operations in direct method.


WuXi Biologics (Cayman) (MEX:2269) Business Description

WuXi Biologics (Cayman) logo
Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (MEX:2269) » Definitions » Other Cash Receipts from Operating Activities
Traded in Other Exchanges
Address
No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092
WuXi Biologics ("WuXi") is a contract development and manufacturing organization, or "CDMO," for biologic drugs. It was founded in 2010 as part of WuXi AppTec and listed on the Hong Kong Stock Exchange in 2017. WuXi provides comprehensive services from conception to commercialization, including drug discovery, clinical and commercial manufacturing, and various support services such as process validation, viral clearance studies, product and cell line characterization, stability studies, and others. It does not conduct clinical trials.